ALB and type 2 diabetes mellitus: Based on the discovery and HSA targeted-phase data and peptide score, we identified 13 peptides that showed strong Cys trioxidation with good Mascot scores that were systematically evaluated for the extent of HSA Cys trioxidation in patients with T2DM and control subjects (Tables 2 and 3) using the MRM method.